國立高雄大學圖資館 |

Retinal degenerative diseases XIXmechanisms and experimental therapy /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Retinal degenerative diseases XIXedited by John D. Ash ... [et al.].
Reminder of title:	mechanisms and experimental therapy /
remainder title:	Retinal degenerative diseases 19
other author:	Ash, John D.
corporate name:
Published:	Cham :Springer International Publishing :2023.
Description:	xix, 588 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Retinal degenerationCongresses.
Online resource:	https://doi.org/10.1007/978-3-031-27681-1
ISBN:	9783031276811$q(electronic bk.)

Retinal degenerative diseases XIXmechanisms and experimental therapy /
Retinal degenerative diseases XIXmechanisms and experimental therapy /[electronic resource] :Retinal degenerative diseases 19edited by John D. Ash ... [et al.]. - Cham :Springer International Publishing :2023. - xix, 588 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v. 14152214-8019 ;. - Advances in experimental medicine and biology ;946..

This book contains the proceedings of the XIX International Symposium on Retinal Degeneration. A majority of those who spoke and presented posters at the meeting contributed to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium focused on the exciting new developments aimed at understanding these diseases and providing therapies for them. These retinal degeneration symposia are known by most as the "best" and "most important" meetings in the field. The volume presents representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. We anticipate that the excitement of those working in the field and those afflicted with retinal degenerations is reflected in the volume.

ISBN: 9783031276811$q(electronic bk.)

Standard No.: 10.1007/978-3-031-27681-1doiSubjects--Topical Terms:

440965
Retinal degeneration
--Congresses.

LC Class. No.: RE661.D3

Dewey Class. No.: 617.735

Retinal degenerative diseases XIXmechanisms and experimental therapy /
LDR:02357nmm a2200337 a 4500 001 648177
003 DE-He213
005 20230713093619.0
006 m d
007 cr nn 008maaau
008 240116s2023 sz s 0 eng d
020 $a 9783031276811$q(electronic bk.)
020 $a 9783031276804$q(paper)
024 7 $a 10.1007/978-3-031-27681-1 $2 doi
035 $a 978-3-031-27681-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RE661.D3
072 7 $a PSAN $2 bicssc
072 7 $a MED057000 $2 bisacsh
072 7 $a PSAN $2 thema
082 0 4 $a 617.735 $2 23
090 $a RE661.D3 $b I61 2021
111 2 $n (3rd : $d 1998 : $c Amsterdam, Netherlands) $3 194767
245 1 0 $a Retinal degenerative diseases XIX $h [electronic resource] : $b mechanisms and experimental therapy / $c edited by John D. Ash ... [et al.].
246 3 $a Retinal degenerative diseases 19
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a xix, 588 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 2214-8019 ; $v v. 1415
520 $a This book contains the proceedings of the XIX International Symposium on Retinal Degeneration. A majority of those who spoke and presented posters at the meeting contributed to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium focused on the exciting new developments aimed at understanding these diseases and providing therapies for them. These retinal degeneration symposia are known by most as the "best" and "most important" meetings in the field. The volume presents representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. We anticipate that the excitement of those working in the field and those afflicted with retinal degenerations is reflected in the volume.
650 0 $a Retinal degeneration $v Congresses. $3 440965
650 1 4 $a Neuroscience. $3 297547
650 2 4 $a Immunology. $3 189152
650 2 4 $a Ophthalmology. $3 274149
700 1 $a Ash, John D. $3 679372
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Advances in experimental medicine and biology ; $v 946. $3 557559
856 4 0 $u https://doi.org/10.1007/978-3-031-27681-1
950 $a Biomedical and Life Sciences (SpringerNature-11642)